ARCT - Arcturus Therapeutics GAAP EPS of -$1.94 misses by $0.63 revenue of $5.24M misses by $1.84M May, 09 2022 04:31 PM Arcturus Therapeutics Ltd. Arcturus Therapeutics press release (NASDAQ:ARCT): Q1 GAAP EPS of -$1.94 misses by $0.63. Revenue of $5.24M (+146.0% Y/Y) misses by $1.84M. For further details see: Arcturus Therapeutics GAAP EPS of -$1.94 misses by $0.63, revenue of $5.24M misses by $1.84M